{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-002057","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.520045+00:00","generated_at":"2026-05-16T10:42:31.819210+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Aspire Biopharma director Surendra Ajjarapu resigns effective Jan 7, 2026","bullets":["Surendra Ajjarapu resigned as Director of Aspire Biopharma, effective January 7, 2026.","Resignation not due to any disagreement with the Company, Board, or management.","No replacement for the vacant director position has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-002057","json":"https://secwatch.observer/filing/0001493152-26-002057.json","markdown":"https://secwatch.observer/filing/0001493152-26-002057.md","text":"https://secwatch.observer/filing/0001493152-26-002057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226002057/0001493152-26-002057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226002057/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:42:31.819210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}